Over-the-counter obesity drug14th June 2007
The UK-based pharmaceutical group GlaxoSmithKline’s weight control drug Alli has been moved from prescription to over-the-counter sales in the US.
It is the first weight control drug to make the switch and is designed to tap into the large and growing concern about obesity.
The drug will be sold in pharmacies and other outlets for about $55 a month but will be closely linked to an advertising campaign that stresses it should only be used in conjunction with weight loss programmes. Alli is also to be filed for regulatory approval in Europe.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Over-the-counter obesity drug
Author: Mark Nicholls
Article Id: 3147
Date Added: 14th Jun 2007